BDR Pharmaceuticals launch Cabozantinib to treat thyroid cancer
In several trials like Celestial (double-blind phase III trial), Phase III Meteor trials, Cabozantinib has shown better PFS (Progression-Free Survival).
In several trials like Celestial (double-blind phase III trial), Phase III Meteor trials, Cabozantinib has shown better PFS (Progression-Free Survival).
The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities
The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others
Incorporating multi-modality image guidance, Ethos therapy provides the ability to personalize the patient's treatment based on their anatomy and position at the time of treatment
This clinical study demonstrated that the 14-day regimen of ImmunoSEB and ProbioSEB CSC3 resolved post-Covid-19 fatigue symptoms and improved patients' functional status and quality of life
This low-cost and highly reliable technology will help in increasing testing in rural and tribal areas
The hospital through its network performs more than 10,000 joint replacement surgeries annually
The institute will provide the world’s first unique and comprehensive capability to predict, prevent, respond and to recover from future pandemics
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
Subscribe To Our Newsletter & Stay Updated